Hunting Hill Global Capital’s Celgene Corp CELG Stock Holding History

Hunting Hill Global Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-603,045	Closed	-$59.9M	–	30
2019 Q3	$59.9M	Buy	603,045 +52,245	+9%	+$4.96M	14.99%	3
2019 Q2	$50.9M	Sell	550,800 -140,000	-20%	-$13.3M	8.44%	5
2019 Q1	$65.2M	Buy	+690,800	New	+$60.4M	11.99%	3

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Hunting Hill Global Capital's CELG Position: Q4 2019 in Review

Hunting Hill Global Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 603,045 shares — an estimated $59.9M sold.

Hunting Hill Global Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $65.2M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Hunting Hill Global Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Hunting Hill Global Capital sold 603,045 Celgene Corp shares in Q4 2019, an estimated $59.9M.
Hunting Hill Global Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Hunting Hill Global Capital's Celgene Corp position peaked at $65.2M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hunting Hill Global Capital's 13F filing for Q4 2019, filed 14 Feb 2020.